Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

New York, Jan 5, 2026, 14:26 EST — Regular session

  • Sunrun shares down about 6% in afternoon trade, underperforming most solar peers
  • Investors watch for comments at Goldman Sachs Energy, Cleantech & Utilities Conference this week
  • Friday’s U.S. jobs report looms as markets reassess the interest-rate path

Sunrun Inc shares fell 5.6% on Monday, a sharp underperformer in U.S. solar, as investors weighed fresh U.S. economic data and looked ahead to a key jobs report later this week. The stock was down $1.08 at $18.36 in afternoon trade.

The move matters because Sunrun’s rooftop solar business leans heavily on financing, and shifts in interest-rate expectations can quickly change customer economics and investor appetite for the sector. Traders were also scanning for any read-through on demand and pricing as the first full week of 2026 gets underway. Reuters

The broader market was higher, with Wall Street’s main indexes rising as investors rotated into financials and energy stocks. That left Sunrun’s drop looking more company-and-sector specific than a simple risk-off move. Reuters

Elsewhere in solar, Enphase Energy and SolarEdge Technologies were both up about 1%, while First Solar fell about 2%. Sunrun traded between $17.77 and $20.00 on the day, underscoring the stock’s volatility.

Investors are also watching for any remarks from Sunrun executives around the Goldman Sachs Energy, Cleantech & Utilities Conference in Miami, scheduled for Jan. 5–7, according to the company’s investor calendar. Sunrun Inc.

On the macro front, U.S. manufacturing contracted more than expected in December, extending a months-long slump, a Reuters report said. The Institute for Supply Management’s manufacturing PMI fell to 47.9; readings below 50 signal contraction. Reuters

Inflation remains the other pressure point for rate-sensitive stocks. ISM’s “prices paid” index — a gauge of input costs — held at 58.5, which the report said has helped keep inflation above the Federal Reserve’s 2% target. Reuters

“While a less fluid trade environment and somewhat more favorable business tax environment are positives for activity, we remain cautious on the extent of recovery in traditional cap-ex categories this year,” Shannon Grein, an economist at Wells Fargo, said in the Reuters report. Reuters

For Sunrun, rates matter because many customers opt for leases or long-term power contracts rather than buying systems outright. Higher borrowing costs can lift monthly payments and tighten the financing markets the industry relies on, which tends to hit valuation multiples when rate expectations shift.

But the stock’s direction is not locked in. Any upbeat tone from management at this week’s conference — or signs that inflation pressures are easing — could help stabilize solar names, while a hotter-than-expected jobs print could revive “higher for longer” rate worries and keep pressure on the group. Sunrun Inc.

Stock Market Today

  • Archrock Looks Undervalued After Multi-Year Rally; DCF Signals 47% Gap
    January 8, 2026, 8:25 PM EST. Archrock (AROC) traded at $26.06, with 7-day and 30-day gains and a mixed year-to-date performance. Over 1 year the stock rose about 6%, ~208% over 3 years, and ~231% over 5 years. The stock is scored as undervalued, with a valuation score of 5 out of 6. A Discounted Cash Flow (DCF) model places the intrinsic value at about $49.62 per share, implying roughly a 47.5% discount to the current price. The stock's P/E ratio of 17.43x sits below Energy Services peers and broader benchmarks (industry average ~19.80x; peers ~30.22x). The analysis notes a lag in 1-year return versus peers, and presents a framework that extends beyond a single model. Investors should compare with fundamentals and growth outlook.
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing
Previous Story

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook
Next Story

Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook

Go toTop